Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anirudh Avadhani"'
Publikováno v:
ACS applied bio materials. 3(10)
Type-1 diabetes (T1D) is caused by immune-mediated destruction of insulin-producing beta-cells, resulting in insulin deficiency and hyperglycemia. Islet transplantation is a potential treatment for T1D, but clinical implementation is hampered by isle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::468d82588ca41b0470ed0ea852615977
https://pubmed.ncbi.nlm.nih.gov/35019389
https://pubmed.ncbi.nlm.nih.gov/35019389
Autor:
Mehmet Giray Ogut, George Duncan, Anirudh Avadhani, Ekin Erin Atila, Utkan Demirci, Rakhi Gupta, Merve Goksin Karaaslan, Leonard Klevan, Fatih Inci
Publikováno v:
Forensic Science International: Genetics
Rapid and efficient processing of sexual assault evidence will accelerate forensic investigation and decrease casework backlogs. The standardized protocols currently used in forensic laboratories require the continued innovation to handle the increas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fd26cb1bad961aee375c08679e33bd2
https://aperta.ulakbim.gov.tr/record/235358
https://aperta.ulakbim.gov.tr/record/235358
Autor:
Utkan Demirci, Amideddin Mataji-Kojouri, Yitian Zeng, Pir Ahmad Shah, Merve Goksin Karaaslan, Yeşeren Saylan, Robert Sinclair, Anirudh Avadhani, Daryl T.-Y. Lau, Fatih Inci
Publikováno v:
Applied Materials Today
Nanoparticles that can assemble and bind selectively on surfaces in intricate geometries can trigger multiple plasmonic modalities and enable wide applications in agriculture such as pesticide monitoring, in medical imaging such as targeted cancer de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb022e2cd407c42693dbe1172ee18b26
https://hdl.handle.net/11693/75517
https://hdl.handle.net/11693/75517
Autor:
Anirudh Avadhani, Mehmet Giray Ogut, Kaushik Sridhar, Joseph C. Wu, Mehmet Ozgun Ozen, Yukari Kobayashi, Akash Shanmugam, Francois Haddad, Utkan Demirci
Publikováno v:
Biosensorsbioelectronics. 150
Microfluidic technologies offer new platforms for biosensing in various clinical and point-of-care (POC) applications. Currently, at the clinical settings, the gold standard diagnostic platforms for multiplexed sensing are multi-step, time consuming,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccb9f5fd21f9456bf99981a4e64692bf
https://pubmed.ncbi.nlm.nih.gov/31929083
https://pubmed.ncbi.nlm.nih.gov/31929083